Our previous studies have shown that CD133+ HCC cells are of high tumorigenicity and chemotherapy resistance, with high expression of a number of stemness genes, and these cells could be induced to differentiate by exogenous BMP4 treatment, demonstrating that CD133 is also a CSC marker in HCC6, 7, 8. Here, PROM1 is linked to hepatocellular carcinoma.